IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.615
EU - Europa 3.214
AS - Asia 1.901
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 6
SA - Sud America 6
OC - Oceania 1
Totale 8.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.599
CN - Cina 708
IE - Irlanda 683
UA - Ucraina 618
SG - Singapore 602
IT - Italia 495
TR - Turchia 468
SE - Svezia 462
GB - Regno Unito 248
DE - Germania 206
FR - Francia 170
FI - Finlandia 128
RU - Federazione Russa 113
IN - India 56
BE - Belgio 22
IR - Iran 22
PL - Polonia 18
VN - Vietnam 17
CA - Canada 14
NL - Olanda 11
AT - Austria 10
EU - Europa 10
HK - Hong Kong 9
CZ - Repubblica Ceca 8
BR - Brasile 5
EG - Egitto 5
RO - Romania 5
IL - Israele 4
DK - Danimarca 3
JP - Giappone 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
MX - Messico 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BJ - Benin 1
CH - Svizzera 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
RS - Serbia 1
VE - Venezuela 1
Totale 8.754
Salva come PNG Salva come JPEG
Città #
Jacksonville 750
Dublin 664
Chandler 649
Singapore 518
Princeton 335
Izmir 223
Nanjing 199
Southend 192
Ashburn 147
Altamura 118
Cambridge 115
Santa Clara 115
Dearborn 114
Wilmington 112
Beijing 110
Nanchang 84
Ann Arbor 79
Chieti 60
Los Angeles 40
Boardman 39
Hebei 39
Shenyang 39
Woodbridge 38
Kunming 34
Pescara 33
New York 29
Tianjin 26
Washington 24
Augusta 23
Jiaxing 23
San Mateo 23
Brussels 22
Changsha 22
Grevenbroich 22
Munich 22
Norwalk 22
Leawood 20
Ardabil 17
Helsinki 17
Teramo 17
Camerino 15
Dong Ket 15
Falls Church 15
Kraków 15
Hangzhou 14
Guangzhou 12
Houston 11
Hefei 10
Rome 10
Milan 9
Toronto 9
Brno 8
Hong Kong 8
Lanzhou 8
Shanghai 8
Seattle 7
Taizhou 7
Amsterdam 6
Jinan 6
Monmouth Junction 6
Moscow 6
Bologna 5
Cairo 5
Düsseldorf 5
Messina 5
Roslyn Heights 5
Auburn Hills 4
Bari 4
Beersheba 4
Brindisi 4
Fort Worth 4
Frankfurt am Main 4
Fuzhou 4
L'aquila 4
Lappeenranta 4
Mumbai 4
Ottawa 4
Paris 4
Redwood City 4
Romola 4
Tappahannock 4
Vienna 4
Zhengzhou 4
Ascoli Piceno 3
Bangalore 3
Campodipietra 3
Changchun 3
Chicago 3
Chongqing 3
Florence 3
Intra 3
Kocaeli 3
Mountain View 3
Ningbo 3
Nuremberg 3
Penne 3
Pune 3
San Francisco 3
Shenzhen 3
Solofra 3
Totale 5.524
Salva come PNG Salva come JPEG
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 125
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 112
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 112
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 110
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 104
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 100
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 99
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 95
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 92
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 88
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 88
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 88
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 86
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 85
Genetic determinants of blood pressure responses to caffeine drinking 84
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 83
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 83
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 82
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 81
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 80
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 80
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 79
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 79
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 78
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 78
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 77
Facilitated PCI: Rationale, current evidence, open questions and future directions 77
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 76
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 74
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 72
The left atrial appendage: from embryology to prevention of thromboembolism 72
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 72
Coffee: Health Effects 72
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 71
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 70
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 70
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 69
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 69
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 69
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 68
New anticoagulants for atrial fibrillation 67
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 67
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 67
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 67
Cardiovascular and psychological reactivity after caffeine consumption 66
Cardiovascular effects of caffeine during cognitive tasks 66
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 66
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 66
The legacy of ISCHEMIA 66
AF: current and forthcoming antithrombotic therapies 66
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 65
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 65
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 65
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 65
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 64
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 63
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 62
Blood pressure modifications after caffeine intake during cognitive tasks 62
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 60
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 60
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 60
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 59
Measurements of thromboxane production and their clinical significance in coronary heart disease 59
Echocardiographic screening for the anomalous aortic origin of coronary arteries 59
Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension 59
Antithrombotic management 58
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 58
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 58
Nutrigenetics of blood pressure responses to coffee drinking 57
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 57
The AVERROES Trial – Clinical Implications 57
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 56
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 56
Autonomic nervous system dysfunction in obese children 55
Antithrombotic prophylaxis in the elderly with atrial fibrillation 55
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 54
DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1 AND -2 BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 54
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 54
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 54
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 54
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination 54
Effect of fibrinogen concentration on the antiplatelet effect of tirofiban 54
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 54
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 53
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 53
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 53
P6223Relationship between platelet indices and future cardiovascular events: results from a population-based cohort study 53
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 53
Ambulatory blood pressure and risk of new-onset atrial fibrillation in treated hypertensive patients 53
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 52
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 52
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 52
Aspirin Resistance 52
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 51
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 51
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 51
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 51
Images in cardiovascular medicine. Membrane-type subaortic stenosis in the adult. 50
Systolic blood pressure response to coffee is modulated by alpha2B adrenergic receptor I/D polymorphism 50
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin – a persisting dilemma 50
Totale 6.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020666 0 0 0 0 0 0 192 148 62 98 160 6
2020/2021943 129 4 143 25 112 169 22 22 36 101 142 38
2021/2022686 12 5 5 125 80 8 17 62 64 18 70 220
2022/20231.998 181 282 116 193 181 389 138 136 268 23 51 40
2023/2024957 75 17 57 11 51 298 220 46 11 29 29 113
2024/20251.254 168 442 347 83 61 96 57 0 0 0 0 0
Totale 9.371